Pacer Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Pacer Advisors, Inc.
- $35.5 Billion
- Q1 2025
A detailed history of Pacer Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 479,390 shares of AMPH stock, worth $11 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
479,390
Previous 1,350,368
64.5%
Holding current value
$11 Million
Previous $50.1 Million
72.28%
% of portfolio
0.04%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$136 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$55.6 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$50.8 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$36.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$31.1 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.13B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...